The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched Analysis

Adjuvant 5-fluorouracil, folinic acid, and oxaliplatin (FOLFOX6) are widely used for treating resected gastric cancer in clinics in China, but only few clinical trials have investigated its efficacy. Using propensity score matching, we evaluated the efficacy of adjuvant FOLFOX6 following D2 lymphade...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zi-Xian, Yang, Xu-Long, He, Ming-Ming, Wang, Feng, Zhang, Dong-Sheng, Li, Yu-Hong, Zhou, Zhi-Wei, Zhan, You-Qing, Xu, Rui-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845815/
https://www.ncbi.nlm.nih.gov/pubmed/27100411
http://dx.doi.org/10.1097/MD.0000000000003214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845815/
https://www.ncbi.nlm.nih.gov/pubmed/27100411
http://dx.doi.org/10.1097/MD.0000000000003214

Ejemplares similares